English · Not set Change ▾

Language Location Show all languages

Live scores ticker: Off · Turn on

Markets ticker: On · Turn off

Saved in a cookie on this device (and in your account when you are logged in). We never store your IP address.

Entities › name

Beactica Therapeutics

2 headlines · 2 outlets · 2026-10-06 → 2026-10-06 · Wikipedia ↗ · 🔒 Follow

Latest coverage

PR Newswire: Health ·Oct 6, 2026 ☆

Press releases
Country: United States

Beactica Therapeutics selects BEA-28 as a preclinical candidate, a first-in-class TEAD degrader for biomarker-selected cancers

UPPSALA, Sweden, Oct. 6, 2026 /PRNewswire/ -- Beactica Therapeutics AB, a Swedish precision medicine company, today announced the selection of BEA-28 as a preclinical candidate for its TEAD programme, which is aimed at developing novel therapies for a range of aggressive,...

Health Politics Details Archived copy ↗

PR Newswire: Technology ·Oct 6, 2026 ☆

Press releases
Country: United States

Beactica Therapeutics selects BEA-28 as a preclinical candidate, a first-in-class TEAD degrader for biomarker-selected cancers

Health Politics Technology Details Archived copy ↗

Beactica Therapeutics

Latest coverage

Beactica Therapeutics selects BEA-28 as a preclinical candidate, a first-in-class TEAD degrader for biomarker-selected cancers

Beactica Therapeutics selects BEA-28 as a preclinical candidate, a first-in-class TEAD degrader for biomarker-selected cancers

Explore

News

Watch & listen

Understand

Explore

Join

Banana News

Upgrade to unlock this

Keyboard shortcuts

Move

Go

Everywhere